https://assets.capyfin.com/instruments/678fdc13234e27009c5d61a7.png avatar
Cellebrite
🇮🇱 NASDAQ:CLBT
•
Dec 31, 2024

Cellebrite Q4 2024 Earnings Report

Key Takeaways

Cellebrite delivered strong Q4 2024 results, with a 17% YoY revenue increase driven by a 21% rise in subscription revenue. The company maintained strong profitability with a 24.7% non-GAAP operating margin and achieved a net income turnaround from a loss in the previous year.

Total Revenue
$109M
Previous year: $93M
+17.2%
EPS
$0.1
Previous year: $0.11
-9.1%
Dollar-Based Net Retention Rate
124%
Annual Recurring Revenue
$396M
Gross Margin
83.8%
Previous year: 84%
-0.2%
Gross Profit
$91.4M
Previous year: $76.3M
+19.8%
Cash and Equivalents
$192M
Previous year: $303M
-36.7%
Free Cash Flow
$66M
Previous year: $37.2M
+77.3%
Total Assets
$691M
Previous year: $533M
+29.6%

Cellebrite Revenue

Cellebrite EPS

Cellebrite Revenue by Segment

Forward Guidance

Cellebrite expects continued revenue growth in 2025, supported by strong subscription momentum, ARR expansion, and profitability improvements.

Positive Outlook

  • Q1 2025 revenue expected to grow 19%-25% YoY
  • FY 2025 revenue guidance of $480M-$490M (+20%-22% YoY)
  • ARR projected to reach $480M-$495M (+21%-25% YoY)
  • Adjusted EBITDA margin expected to remain at 24%-25%
  • Continued investment in AI and cloud-based solutions

Challenges Ahead

  • Operating margin decline from 16.1% to 14.4% YoY
  • Professional services revenue declined YoY
  • Potential macroeconomic uncertainties impacting customer budgets
  • Competitive landscape in digital intelligence solutions
  • Execution risk in new strategic initiatives

Revenue & Expenses

Visualization of income flow from segment revenue to net income